What is the strength (units per gram) of Nystatin powder and the appropriate dosage regimens for oral thrush and vaginal candidiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nystatin Powder Strength and Dosage

Nystatin powder is standardly formulated at 100,000 units per gram (or 100,000 units per mL for suspensions), with dosing for oral thrush at 400,000-600,000 units (4-6 mL) four times daily for 7-14 days, while vaginal candidiasis requires 100,000 unit pessaries twice daily for 7-14 days. 1, 2, 3

Standard Formulation Strength

Nystatin is consistently manufactured at 100,000 units per mL for oral suspensions and 100,000 units per gram for topical preparations (creams, ointments). 1, 2 This standardization applies across all FDA-approved formulations, whether oral suspension, vaginal tablets, or topical cream.

Dosing for Oral Thrush (Oropharyngeal Candidiasis)

Mild Disease

  • Nystatin suspension (100,000 U/mL): 4-6 mL four times daily for 7-14 days 3
  • Alternative: Nystatin pastilles (200,000 U each): 1-2 pastilles four times daily for 7-14 days 3

The 2016 IDSA guidelines classify this as a strong recommendation with moderate-quality evidence for mild oropharyngeal candidiasis. 3

Important Clinical Considerations for Oral Thrush

Swish-and-swallow technique is critical: The suspension should be retained in the mouth as long as possible before swallowing to maximize mucosal contact time. 1

Combination therapy may be superior: Evidence suggests that using nystatin pastilles and suspension together for 2 weeks achieves higher clinical and mycological cure rates than suspension alone. 4 Additionally, pastilles alone demonstrate better mycological cure rates than suspension monotherapy.

Duration matters: Treatment for 4 weeks with pastilles shows better clinical efficacy than 2-week courses, though standard recommendations remain 7-14 days. 4

Dose-response relationship: Pastilles at 400,000 IU produce significantly higher mycological cure rates than 200,000 IU doses. 4

When Nystatin Is NOT First-Line

For moderate-to-severe oral thrush, oral fluconazole 100-200 mg daily for 7-14 days is preferred (strong recommendation, high-quality evidence). 3 Nystatin should be reserved for mild disease or when azoles are contraindicated.

Dosing for Vaginal Candidiasis

Nystatin vaginal pessaries: 100,000 units twice daily for 7 days 5

However, this is NOT the preferred treatment. The 2022 CDC guidelines and supporting evidence clearly indicate that topical azoles (clotrimazole, miconazole, terconazole) or oral fluconazole 150 mg single dose are superior first-line options for uncomplicated vulvovaginal candidiasis. 6 Nystatin for vaginal candidiasis has fallen out of favor due to:

  • Lower efficacy compared to azoles
  • More frequent dosing requirements
  • Lack of single-dose formulations

The evidence shows nystatin achieves only 81% mycological cure rates versus 87.5% with ketoconazole, though this difference was not statistically significant. 5

Common Pitfalls and Caveats

Sugar Content Warning

Many commercial nystatin suspensions contain significant amounts of sugar (sucrose), which can:

  • Promote dental caries with prolonged use
  • Be problematic for diabetic patients
  • Actually feed Candida organisms

Sugar-free formulations should be specifically requested when available. 7

Comparative Efficacy Concerns

Nystatin suspension is significantly inferior to other agents in certain populations:

  • Not superior to fluconazole in infants, children, or HIV/AIDS patients 4
  • Dramatically inferior to miconazole gel in immunocompetent infants (84.7% vs 21.2% cure rate by day 5) 8
  • Slower clinical response than ketoconazole in newborns (100% vs 53% cure at 1 week) 9

Denture-Related Candidiasis

For denture stomatitis, denture disinfection is mandatory in addition to antifungal therapy (strong recommendation, moderate-quality evidence). 3 Nystatin alone without addressing the denture reservoir leads to high recurrence rates. A denture soaking solution can be prepared by dissolving 48 mL nystatin liquid (100,000 IU/mL) in 432 mL distilled water, producing a 10,000 IU/mL solution. 10

Safety Profile

The most common adverse effects are:

  • Poor taste (major compliance issue)
  • Gastrointestinal upset (nausea, vomiting, diarrhea)
  • Minimal systemic absorption limits serious adverse events 4

When to Escalate Beyond Nystatin

Fluconazole-refractory disease requires escalation to:

  • Itraconazole solution 200 mg once daily, OR
  • Posaconazole suspension 400 mg twice daily for 3 days then 400 mg daily
  • Voriconazole 200 mg twice daily as alternative 3

For immunocompromised patients (HIV, chemotherapy, transplant), systemic azoles should be strongly considered as first-line rather than topical nystatin due to superior efficacy. 3, 11

References

Research

Oral versus local treatment of vaginal candidosis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.